net dbt
improv growth potenti publicli
keep check box multi-year growth plan
tough start pathway forward steadier/mor
sustain growth opportun appear track given third straight quarter
outperform expect underli oper perform shown number
sign bright spot also handl variou industri tailwind current
impact busi overal enterpris appear prepar achiev multi-
year target establish june investor day stock react favor
result still see discount vs histor valuat potenti
re-rat higher benefit aetna transact still year one even
count tunney act overhang much process buy rate
predic abil enterpris transform/adapt new total cost
manag healthcar conveni model anoth quarter
support view reiter buy rate increas price object
increas target multipl price-to-earnings still
discount vs histor averag continu see risk/reward strong cash
flow gener quit appeal current level
increas ep maintain ep
increas ep driven primarili beat includ stronger
ebit growth pharmaci servic well roll-through prior-period
develop beat still expect acceler core profit growth
beyond
upcom event catalyst
way focu remaind year updat
pbm sell season/ma enrol well addit commentari near-term
intermedi term initi expans healthhub model
synergi realiz rx growth key event watch includ legislation/regulatori
updat relat drug price broadli particularli potenti senate/hous
drug price bill potenti execut order
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one largest healthcar compani
unit state provid retail mail
specialti pharmaci dispens servic
pharmaci benefit upon complet
acquisit aetna would becom one
vertic integr publicli trade
healthcar compani base
buy rate driven transform
vertic integr aetna stabl free cash
flow appeal valuat think
compani deal aetna provid ampl short-
term long-term synergi opportun
provid clear way extract valu
retail franchis stabl free cash flow
three busi allow
compani gener outsiz return
equiti next year
increas ep guidanc
healthhub houston month perform outperform
control group key metric
off-set continu reimburs pressur increas gener
dispens rate includ impact new gener drug
introduct increas use gener drug
close store result charg
adjust oper incom declin due continu reimburs
pressur partial off-set script growth front store margin
improv well benefit gener seen
improv
retail store rx volum quarter
pharmaci servic growth due growth specialti growth mainten
net new busi improv sinc updat august
renew relationship fehbi decemb includ
mail retail contract
adjust oper incom driven increas claim volum
shift aetna mail order specialti oper pss
improv purchas econom partial off-set continu price
mbr reflect moder medic cost trend favor prior period
reserv develop commerci govern busi
roll first phase kidney program sever hundr patient
hemodialysi clinic trial progress expect
carepass enrol less month
quarter benefit lower interest expens
thought primari care versu episod care
new well product ad front store done well
minuteclin expans chronic condit believ work
primari care replac
servic provid primari care provid
minuteclin
respons posit date
see pipelin build
focu go market integr
pbm much cross sale compani see aetna book
measur penetr book compani medic
want drive pharmaci integr
effort cross-sel market employ market
peopl excit new digit capabl
earli talk
investor look prior year develop
even confid around lsd growth
compani doesnt guid pyd need remov pyd
compani comfort low
healthhub store year end store
year end
progress omnicar versu
market continu challeng competitor continu divest
perform line expect perform
confid deliv guidanc
guidanc high anyth call
come market
disclosur wellcar around aetna pdp right impact
